These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13412559)

  • 21. Marked increase in Mitsuda positivity in lepromatous cases; with reference to clinical features.
    SATO S; FUKUDA M
    Int J Lepr; 1958; 26(3):205-18. PubMed ID: 13640758
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy.
    Goulart LR; Ferreira FR; Goulart IM
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):91-8. PubMed ID: 16965356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility to leprosy may be conditioned by an interaction between the NRAMP1 promoter polymorphisms and the lepromin response.
    Ferreira FR; Goulart LR; Silva HD; Goulart IM
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):457-67. PubMed ID: 15755200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Initial epidemiological data on the possible preventive action of oral BCG in close contacts of leprosy patients].
    BECHELLI LM; QUAGLIATO R
    Rev Bras Leprol; 1956; 24(1-2):23-36. PubMed ID: 13420740
    [No Abstract]   [Full Text] [Related]  

  • 25. [Possibility of reinforcing the positivity of Mitsuda reactions prepared with dilute antigens without loss of specificity of response].
    FLOCH H
    Bull Soc Pathol Exot Filiales; 1955; 48(3):372-5. PubMed ID: 13304612
    [No Abstract]   [Full Text] [Related]  

  • 26. [Research on the use of diluted lepromins for the immunological control of Mitsuda-positive contacts; experiment carried out in the Providence Leprosary & the Antileprosy Department of the state of Zulia].
    DE ARVELO J J; MOLINENGO L; PEREZ PEREZ B
    Rev Sanid Asist Soc; 1958; 23(1-2):29-38. PubMed ID: 13634635
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal reaction and Mitsuda conversion in polar lepromatous leprosy: a case report.
    Kar BR; Job CK
    Lepr Rev; 2005 Sep; 76(3):258-62. PubMed ID: 16248213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy.
    Velema JP; Ogbeiwi OI
    Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: a case-control study.
    Zodpey SP; Shrikhande SN; Kulkarni SW; Maldhure BR
    Indian J Public Health; 2007; 51(3):184-9. PubMed ID: 18229442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The BCG controversy: a reappraisal of the protective effect against tuberculosis and leprosy.
    Zodpey SP
    Indian J Public Health; 2004; 48(2):70-7. PubMed ID: 15709589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Observations furnished by applied experimentation; BCG in the prevention of leprosy].
    HADLER WA
    Rev Bras Leprol; 1957; 25(4):323-30. PubMed ID: 13568189
    [No Abstract]   [Full Text] [Related]  

  • 32. [Observations furnished by applied experimentation; BCG in the prevention of leprosy].
    AZULAY RD
    Rev Bras Leprol; 1957; 25(4):331-41. PubMed ID: 13568190
    [No Abstract]   [Full Text] [Related]  

  • 33. Leprosy and tuberculosis: a comparative study with the aid of skin tests with tuberculin, killed BCG, and the Dharmendra lepromin in South African Bantus.
    KOOIJ R; RUTGERS AW
    Int J Lepr; 1958; 26(1):24-40. PubMed ID: 13586953
    [No Abstract]   [Full Text] [Related]  

  • 34. [Review of the lepromin reaction and immunity to leprosy, 1933-1953].
    ROTBERG A
    Rev Bras Leprol; 1955; 23(1-4):1-22. PubMed ID: 13389914
    [No Abstract]   [Full Text] [Related]  

  • 35. [Verification of the effect of BCG in leprosy patients during therapy; histopathological confirmation of lepromin reactions].
    RABELO NETO AV; AZULAY RD; OLIVEIRA SILVA EC; ANDRADE LM
    Rev Bras Leprol; 1956; 24(1-2):48-55. PubMed ID: 13420742
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reversal of the lepromin reaction after retesting in children under 4 years of age].
    BECHELLI LM; SOUZA RP
    Rev Bras Leprol; 1961 Mar; 29():13-8. PubMed ID: 13688358
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunity in leprosy].
    DE BASTO PM
    J Med (Oporto); 1957 Jul; 33(754):485-9. PubMed ID: 13448824
    [No Abstract]   [Full Text] [Related]  

  • 38. Long lasting BCG protection against leprosy.
    Rodrigues LC; Kerr-Pontes LR; Frietas MV; Barreto ML
    Vaccine; 2007 Sep; 25(39-40):6842-4. PubMed ID: 17728023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution to the study of the value of BCG. Relation to the lepromin test in childhood].
    de ALMEIDA S; BLAST R
    Pediatr Prat; 1960 May; 31():157-90. PubMed ID: 13682626
    [No Abstract]   [Full Text] [Related]  

  • 40. Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
    Sousa AL; Stefani MM; Pereira GA; Costa MB; Rebello PF; Gomes MK; Narahashi K; Gillis TP; Krahenbuhl JL; Martelli CM
    Am J Trop Med Hyg; 2007 Nov; 77(5):829-33. PubMed ID: 17984336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.